Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition.

Adeno-associated virus (AAV) is a nonpathogenic, single-stranded DNA virus belonging to the parvoviridae family. Onco-suppressive properties of AAV against adenovirus, a DNA tumor virus, have been well documented. Rep78, a major regulatory protein of AAV, is believed to be responsible for its antioncogenic properties. Most DNA tumor viruses disturb the cell cycle pathways by essentially abrogating the functions of p53. Here we present evidence that AAV acts as an antiproliferative agent against adenovirus by protecting the adenoviral-mediated degradation of p53 as confirmed by both Western blot analysis and immunoprecipitation analysis with anti-p53 antibody. Coimmunoprecipitation experiments revealed that the AAV Rep78 is physically bound to p53 in vivo. Furthermore, the binding of purified p53 to the AAV Rep78 affinity column confirms their interaction. These results document for the first time that the antiproliferative effects of AAV against adenovirus are mediated, at least in part, by the interaction of AAV Rep78 with p53.

[1]  D. Haber,et al.  E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells , 1998, Oncogene.

[2]  S. Ponnazhagan,et al.  Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells , 1997, Journal of virology.

[3]  D. Livingston,et al.  The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. , 1996, Genes & development.

[4]  R. Batchu,et al.  The adeno-associated virus Rep78 major regulatory/transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect. , 1996, Cancer research.

[5]  A. Ciechanover,et al.  Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2. , 1994, The Journal of biological chemistry.

[6]  J. Schlehofer,et al.  The tumor suppressive properties of adeno-associated viruses. , 1994, Mutation research.

[7]  K. Datta,et al.  Simultaneous determination of native and subunit molecular weights of proteins by pore limit electrophoresis and restricted use of sodium dodecyl sulfate , 1993, Electrophoresis.

[8]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[9]  J. Trempe,et al.  Mutational analysis of the adeno-associated virus rep gene , 1992, Journal of virology.

[10]  D. Housman,et al.  Targeted integration of adeno‐associated virus (AAV) into human chromosome 19. , 1991, The EMBO journal.

[11]  Im Neuenheimer Feld,et al.  The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification , 1990, Journal of virology.

[12]  R. Samulski,et al.  A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication , 1987, Journal of virology.

[13]  K. Berns,et al.  Adeno-associated viruses: an update. , 1987, Advances in virus research.

[14]  H. zur Hausen,et al.  Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. , 1984, Virology.

[15]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.

[16]  B. Carter,et al.  Inhibition of adenovirus oncogenicity in hamsters by adeno-associated virus DNA. , 1981, Journal of the National Cancer Institute.

[17]  K. Berns,et al.  Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. , 1981, Virology.

[18]  Fry De,et al.  Inhibition and enhancement of avian adenovirus plaque production by heavy and light avian adenovirus-associated viral particles. , 1979 .

[19]  A. Pronovost,et al.  Inhibition and enhancement of avian adenovirus plaque production by heavy and light avian adenovirus-associated viral particles. , 1979, American journal of veterinary research.

[20]  C. Gorman,et al.  Hamster embryo cells transformed by herpes simplex virus: reactions with adeno-associated satellite virus (AAV) and its adenovirus helpers. , 1977, Cancer biochemistry biophysics.

[21]  H. D. Mayor,et al.  Influence of adeno-associated satellite virus on adenovirus-induced tumours in hamsters. , 1973, Nature: New biology.

[22]  B. Casto,et al.  Inhibition of Adenovirus Transformation in Vitro by AAV-1 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  D. Dekegel,et al.  COMPLEMENT-FIXATION ANTIBODIES TO ADENOVIRUS-ASSOCIATED VIRUSES, ADENOVIRUSES, CYTOMEGALOVIRUSES AND HERPES SIMPLEX VIRUSES IN PATIENTS WITH TUMORS AND IN CONTROL INDIVIDUALS , 1971 .

[24]  D. Dekegel,et al.  Complement-fixation antibodies to adenovirus-associated viruses, cytomegaloviruses and herpes simplex viruses in patients with tumors and in control individuals. , 1971, American journal of epidemiology.

[25]  C. S. Cox Method for the Routine Preservation of Micro-organisms , 1968, Nature.

[26]  R. Huebner,et al.  Oncogenicity of Mixtures of Adeno-associated Virus and Adenovirus Type 12 , 1968, Nature.